14. Income Taxes

The Company has not recorded any income tax expense for the years ended December 31, 2025 and 2024 due to its history of operating losses. The loss from continuing operations before income tax consists of the following (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2025

 

 

2024

 

United States

 

$

(31,928

)

 

$

(32,898

)

Foreign

 

 

 

 

 

 

Total

 

$

(31,928

)

 

$

(32,898

)

The provision for income taxes includes the following components (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2025

 

 

2024

 

Current:

 

 

 

 

 

 

Federal

 

$

 

 

$

 

State

 

 

 

 

 

 

Foreign

 

 

 

 

 

 

Total current (benefit) provision

 

$

 

 

$

 

Deferred:

 

 

 

 

 

 

Federal

 

$

(6,789

)

 

$

(8,981

)

State

 

 

(889

)

 

 

(4,198

)

Foreign

 

 

 

 

 

 

Change in valuation allowance

 

 

7,678

 

 

 

13,179

 

Total deferred (benefit) provision

 

$

 

 

$

 

Total income tax (benefit) provision

 

$

 

 

$

 

 

The (benefit) provision for income taxes differs from the amount computed at federal statutory rates as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2025

 

 

2024

 

U.S. federal statutory tax rate

 

$

(6,705

)

 

 

21.00

%

 

$

(6,908

)

 

 

21.00

%

State and local income tax effects, net of federal income tax benefit(1)

 

 

 

 

 

%

 

 

 

 

 

%

Foreign tax effects

 

 

 

 

 

%

 

 

 

 

 

%

Effects of changes in tax laws or rates enacted in current period

 

 

 

 

 

%

 

 

 

 

 

%

Tax credits

 

 

 

 

 

 

 

 

 

 

 

 

R&D credits

 

 

(348

)

 

 

1.09

%

 

 

(699

)

 

 

2.13

%

Change in valuation allowance

 

 

6,708

 

 

 

(21.01

)%

 

 

8,956

 

 

 

(27.23

)%

Nontaxable or nondeductible items

 

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation

 

 

(50

)

 

 

0.16

%

 

 

(2,366

)

 

 

7.19

%

Nondeductible officer compensation

 

 

168

 

 

 

(0.53

)%

 

 

986

 

 

 

(3.00

)%

Other

 

 

227

 

 

 

(0.71

)%

 

 

31

 

 

 

(0.09

)%

Income tax (benefit) provision

 

$

 

 

 

%

 

$

 

 

 

%

(1) 2025 State taxes in California made up a majority (greater than 50%) of the tax effect in this category.

 

 

Significant components of the Company’s net deferred income tax assets and liabilities are as follows (in thousands):

 

 

 

December 31,

 

 

 

2025

 

 

2024

 

Deferred tax assets:

 

 

 

 

 

 

Net operating loss carryforwards

 

$

70,631

 

 

$

61,615

 

R&D credits

 

 

5,128

 

 

 

4,693

 

R&E expenses

 

 

6,210

 

 

 

8,127

 

Accruals and reserves

 

 

638

 

 

 

409

 

Stock-based compensation

 

 

3,083

 

 

 

3,193

 

Depreciation and amortization

 

 

57

 

 

 

5

 

Lease liability

 

 

602

 

 

 

184

 

Other

 

 

6

 

 

 

7

 

Total deferred tax asset before allowance

 

 

86,355

 

 

 

78,233

 

Less: valuation allowance

 

 

(85,736

)

 

 

(78,058

)

Total deferred tax asset

 

 

619

 

 

 

175

 

Deferred tax liabilities:

 

 

 

 

 

 

Right-of-use asset

 

 

(619

)

 

 

(175

)

Depreciation and amortization

 

 

 

 

 

 

Net deferred tax assets

 

$

 

 

$

 

 

Management assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to use the existing deferred tax assets. A significant piece of objective negative evidence evaluated is the cumulative loss incurred since inception. Such objective evidence limits the ability to consider other subjective evidence such as the Company’s projections for future growth.

On the basis of this evaluation, a full valuation allowance of $85.7 million and $78.1 million has been recorded as of December 31, 2025 and 2024, respectively, as it is more likely than not that the deferred tax assets will not be realized. The valuation allowance increased by $7.7 million and $13.2 million for the years ended December 31, 2025 and 2024, respectively, and there is no tax benefit presented in the accompanying financial statements.

The Company is subject to minimum taxes in several of the state jurisdictions where it files income tax returns. The amounts paid are immaterial and not presented above as a component of the current state tax provision. Besides these minimum state taxes, the Company did not pay any federal, state, or foreign taxes.

As of December 31, 2025, the Company had U.S. federal and state net operating loss carryforwards of approximately $275.8 million and $205.4 million, respectively. Of the federal amount, $205.5 million can be carried forward indefinitely, while the remainder begins to expire after 2028, if not utilized. The state amounts begin to expire at various dates after 2030.

Because of the change of ownership provisions of the Tax Reform Act of 1986, use of a portion of the Company’s NOL and tax credit carryforwards may be limited in future periods. Further, a portion of the carryforwards may expire before being applied to reduce future income tax liabilities. There are currently no federal or state tax audits in progress. All prior tax years remain subject to examination by Federal and State of Utah authorities due to the existence of net operating loss carryforwards.

The Company recognizes the tax benefit of an uncertain tax position only if it is more likely than not that a tax position will be sustained upon examination by the appropriate taxing authorities, based on technical merits. The reversal of the uncertain tax positions would not affect the Company’s effective tax rate to the extent that it continues to maintain a full valuation allowance against its deferred tax assets. As of December 31, 2025 and 2024, the Company did not record any material interest expense or penalties related to uncertain tax positions or the settlement of audits for prior periods. A reconciliation of the beginning and ending amount of uncertain tax positions (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2025

 

 

2024

 

Balance at the beginning of the year

 

$

3,129

 

 

$

2,570

 

Gross increases—prior period

 

 

 

 

 

 

Gross increases—current period

 

 

290

 

 

 

559

 

Balance at the end of the year

 

$

3,419

 

 

$

3,129

 

Historical Timeline

Fiscal YearFiled
2025Mar 18, 2026Showing above
2024Mar 19, 2025
2023Mar 20, 2024
2022Mar 22, 2023
2021Mar 29, 2022

About Income Taxes Disclosures

The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.

Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.